Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼Ò°£¼¼Æ÷¾ÏÀÇ °æÇÇÀû ¿¡Åº¿Ã ÁÖÀÔ ¿ä¹ý : ´Ü±â Ä¡·á ¼ºÀûÀ» Áß½ÉÀ¸·Î ¿¹ÈÄÀÎÀÚ ºÐ¼® Percutaneous Ethanol Injection Therapy (PEIT) for Small Hepatocellular Carcinomas (HCCs) : Prognostic Factors Affecting Short-Term Follow-up Results

´ëÇѹæ»ç¼±ÀÇÇÐȸÁö 1998³â 38±Ç 6È£ p.1051 ~ 1057
¼Ò¼Ó »ó¼¼Á¤º¸
±è¾Æ¿µ/Ah Young Kim ÇÑÁر¸/±èÅ°æ/À±ÀºÁÖ/À̱⿭/ÃÖº´ÀÎ/Joon Koo Han/Tae Kyoung Kim/Eun Joo Yun/Ki Yeol Lee/Byung Ihn Choi

Abstract

¸ñ Àû : °æÇÇÀû ¿¡Åº¿Ã ÁÖÀÔ ¿ä¹ýÀ» ½Ã¼ú¹ÞÀº ¼Ò°£¼¼Æ÷¾ÏÀÇ ´Ü±â Ä¡·á ¼ºÀûÀ» Áß½ÉÀ¸·Î ½Ã
¼ú¿¡ °ü¿©ÇÏ´Â ¿©·¯ ÀÎÀÚµé°ú Ä¡·á ¼ºÀû°£ÀÇ ºñ±³ºÐ¼®À» ÅëÇØ ´Ü±â Ä¡·á ¼ºÀû¿¡ À־ÀÇ
¿¹ÈÄ ÀÎÀÚ¸¦ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : Á¶Á÷»ý°ËÀ̳ª, ÀÓ»ó¼Ò°ß, Á¾¾çÇ¥½Ä¹°Áú, Ç÷°üÁ¶¿µ¼ú ¹× ±âŸ ¿µ»ó °Ë»çµîÀ¸
·Î Áø´ÜÇÑ °£¼¼Æ÷¾Ï ȯÀÚÁß 1993³â 11¿ùºÎÅÍ 1996³â 10¿ù±îÁö ½ÃÇà¹ÞÀº 63¸í(76°³ º´¼Ò)ÀÇ
18°³¿ù°£ÀÇ ´Ü±â Ä¡·á¼ºÀûÀ» ºÐ¼®ÇÏ¿´´Ù. ´ë»óº´º¯Àº Á¾¾çÀÇ Àå°æÀÌ 3cmÀÌÇÏÀÌ°í ÃÑ °¹¼ö
°¡ 3°³ ÀÌÇϷμ­ ¿Ü°úÀû ÀýÁ¦¼ú°ú °æµ¿¸Æ È­ÇлöÀü¼úÀÇ ÀûÀÀÀÌ ºÎÀûÀýÇÑ °æ¿ì·Î Á¦ÇÑÇÏ¿´
´Ù. ÃÑ 63¸íÀÇ È¯ÀÚÁß 51¸í(64°³ º´¼Ò)¿¡¼­ ½Ã¼ú 1°³¿ù ÈÄ¿¡ ÀÌÁ߽ñ⠿ªµ¿Àû CT·Î Á¾¾ç¿¡
´ëÇÑ Ãʱâ ÃßÀû °Ë»ç¸¦ ½ÃÇàÇÏ¿´À¸¸ç 12¸í(12°³ º´¼Ò)¿¡¼­´Â ½Ã¼ú ÈÄ 2°³¿ù °£°ÝÀ¸·Î 3ȸÀÇ
ÃÊÀ½ÆÄ ÃßÀû °Ë»ç¸¦ ½ÃÇàÇÏ¿´´Ù. ÀÌ·¯ÇÑ ÃßÀû °Ë»ç °á°ú¸¦ Åä´ë·Î Ä¡·á ¼ºÀûÀ» Æò°¡ÇÏ°í, º´
¼ÒÀÇ Å©±â, ½Ã¼ú ȸ¼ö, ¿¡Åº¿Ã ÁÖÀÔ ÃÑ·® ¹× Á¾¾ç ¿ëÀû ´ç ÁÖÀÔ ÃÑ·®ÀÇ ºñÀ², Child-Pugh ºÐ
·ù µî±Þ, ½Ã¼ú ÀüÀÇ ¾ËÆÄžƴܹé(¥á-fetoprotein : ÀÌÇÏ AFP) ¼öÄ¡ µîÀÇ ´Ù¾çÇÑ º¯¼ö°¡ °¢
°¢ Ä¡·á È¿°ú¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù.
°á °ú : Ä¡·á ¼ºÀûÀ» ¿ÏÀü °üÇØ, ºÎºÐ °üÇØ, ¹«¹ÝÀÀ/¾ÇÈ­·Î ºÐ·ùÇÏ¿´À» ¶§ ¿ÏÀü °üÇØ°¡ 45
°³ º´¼Ò(59.2%), ºÎºÐ °üÇØ°¡ 18°³ º´¼Ò(23.7%), ¹«¹ÝÀÀ/¾ÇÈ­°¡ 13°³ º´¼Ò(17.1%)·Î Àüü °ü
ÇØÀ²Àº 82.9%¿´´Ù. Ä¡·á È¿°ú¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿©·¯ º¯¼ö Áß¿¡¼­ Á¾¾çÀÇ Å©±â°¡ ÀÛÀ»¼ö·Ï,
Child µî±ÞÀÌ ÁÁÀ» ¼ö·Ï, ½Ã¼ú ȸ¼ö°¡ ¸¹À» ¼ö·Ï, Á¾¾ç ¿ëÀû ´ç ÁÖÀÔ ÃÑ·®ÀÇ ºñ°¡ Ŭ¼ö·Ï,
¿ì¼öÇÑ Ä¡·á È¿°ú¸¦ º¸¿´À¸¸ç ÀÌ´Â Åë°èÀûÀ¸·Î À¯ÀÇÇÑ »ó°ü °ü°è¸¦ º¸¿´´Ù(Spearman test ;
p<0.05).
°á ·Ð : ¼Ò°£¼¼Æ÷¾Ï¿¡ ´ëÇÑ °æÇÇÀû ¿¡Åº¿Ã ÁÖÀÔ¹ýÀÇ ½Ã¼ú¿¡ ÀÖ¾î ´Ü±â Ä¡·á ¼ºÀû¿¡ ¿µÇâÀ»
¹ÌÄ¡´Â »ó±â ¿¹ÈÄ ÀÎÀڵ鿡 ´ëÇÑ ÃæºÐÇÑ ÀÌÇظ¦ °¡Áö°í º¸´Ù Á¶±â¿¡ ÀûÀýÇÑ ½Ã¼úÀ» ÇÑ´Ù¸é
°£¼¼Æ÷¾Ï¿¡ ´ëÇÑ Ä¡·á È¿°ú¸¦ Å©°Ô Çâ»ó½Ãų ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.
#ÃÊ·Ï#
Purpose : To analyze the effect of various parameters used in PEIT on the short-term
results of this procedure for the treatment of small HCC.
Materials and Methods : Among 76 lesions in 63 patients with HCCs, 66 were
diagnosed by tissue biopsy (n=30) or according to clinical features, tumor marker, and
the results of angiography and other diagnostic imagings(n=36). These patients
underwent PEIT between November 1993 and October 1996 ; the indications for PEIT
were nodular lesions less than 3cm in size, less than three in number, and unsuitable
for surgical resection or transcatheter arterial chemoembolization threpy. The effect of
PEIT was evaluated by two phase spiral CT one month later (64 lesions) or by serial
ultrasound for 6 months. We analyzed and graded the short-term effect of PEIT on
HCCs as complete remission(CR), partial remission(PR) or no
change/aggravation(NC/AG). We also evaluated the correlation between the short-term
results of PEIT and variable parameters such as size of the lesion, frequency of PEI per
session, Child classification of the patient, the ratio of amount of injected ethanol per
volume of the lesion, and ¥á-fetoprotein level before the procedure.
Results : The therapeutic effect of PEIT was CR in 45 lesions(59.2%), PR in 18(23.7%)
and NC/AG in 13(17.1%). The size of the tumor, Child-Pugh class, number of injections
per session and ratio of injected volume of ethanol to tumor volume were factors
affecting the therapeutic result(p<0.05).
Conclusion : Sufficient knowledge of prognostic factors affecting the short-term results
of PEIT might help improve the effects of therapy in patients its small HCCs.

Å°¿öµå

Liver neoplasms; US; Alcohol; Neoplasms; therapy;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS